Fresh analysis suggests that individuals who come off new slimming jabs like Mounjaro or Wegovy can put back on shed pounds at a significantly accelerated pace than those who stop traditional lifestyle regimens.
Research printed in a leading medical journal points out that while obese individuals can lose substantial amounts of their total mass while undergoing treatment, the mass is regained at an estimated rate of nearly a kilo each month once they quit.
"Users using such drugs must be cognizant of the risk of rapid weight regain when the therapy ends," stated expert Dr. Susan Jebb.
That rate of regain suggests a reversion to original mass within about a year and a half.
Weighing Therapies
The study, which reviewed 37 of studies involving over 9,000 of patients, compared the outcomes of the injectable medications with conventional dieting.
Scientists note that people who shed pounds through lifestyle changes alone typically see a slower weight regain—approximately 100 grams monthly—once they finish.
Explaining the Fast Rebound
Experts believe the way of the jabs is key to understanding the accelerated regain.
The injections imitate a natural hormone called glucagon-like peptide-1, which moderates hunger.
"Artificially providing the hormone levels far above than normal may cause the body to produce less of its own natural GLP-1, and could diminish sensitivity to its actions," noted Dr. Adam Collins, a nutrition expert.
"Stopping of this GLP-1 'fix' leads to hunger is no longer kept in check, making binge eating far more likely."
An Ongoing Disease?
Medical guidelines advise the injections for individuals with obesity-related health risks, alongside recommended diet and exercise modifications.
Many experts argue that, considering the significant potential of weight regain, the treatment should be considered life-long.
This opinion is supported by drug manufacturers, who state that the results "underscore the persistent nature of obesity," comparing it to managing diseases like diabetes.
User Experiences
Users who have come off the jabs explain a sudden return of hunger.
"It was like a switch flipping and you're instantly ravenous," recalled one woman.
The struggle is exacerbated if patients have not developed permanent lifestyle or habit modifications during therapy.
Widespread Adoption
Recent estimates indicate that a significant number of adults in the UK have used weight-loss jabs in the past year, with demand remaining high.
- Adoption is greater among women than males.
- The middle-aged demographic shows the greatest level of interest.
- A large proportion obtain the drugs through private healthcare rather than public health services.
In conclusion, researchers stress that while GLP-1 drugs are effective agents for weight loss, they are not a standalone fix and lasting health benefits relies on ongoing lifestyle changes.
